In addition, an experimental validation was also carried out; the exogenous addition of recombinant IFN-γ (50 ng/mL) was sufficient to induce a significant upregulation of Ido1 at both transcriptional and translational levels in MC38 tumor cells (Figure 2K). The gene discussed is IDO1; the disease is neoplasm.